To further delineate the observed heterogeneous patterns of CNAs, allelic imbalances and gene expression patterns in the three mutational groups identification and/or definition of new molecular subgroups within the EGFR-mutated, KRAS-mutated and EGFRwt/KRASwt tumor groups are needed. This evidence concerns the gene KRAS and neoplasm.